BDX vs GCTK · P/E 34, rev $21.84B vs P/E 0.1, $4.1M cap
Becton Dickinson and Company (BDX) versus GlucoTrack Inc (GCTK) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
GlucoTrack Inc (GCTK) is a medical instruments & supplies company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
GCTK does not have a complete income-statement cache yet.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. GCTK currently screens at market cap $4.1M and trailing P/E 0.1.
Not investment advice. Open the BDX and GCTK stock pages for the full models.
Not investment advice.